Header Logo

Connection

Randall Pellish to Cost Savings

Back to Details
This is a "connection" page, showing publications Randall Pellish has written about Cost Savings.
Randall Pellish
Connection Strength
0.902
Cost Savings
  1. Cappuccio JM, Mehta N, Pellish R. Inpatient Infliximab Biosimilar Cost-Savings: Cost Analysis of Inpatient Treatment with Originator Infliximab (Remicade?) versus Biosimilar Infliximab (Renflexis?) for Acute Severe Ulcerative Colitis. Dig Dis. 2024; 42(5):496-502.
    View in: PubMed
    Score: 0.902
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.